Abstract
The role of CD8+ T cells in multiple sclerosis (MS) and its animal models has been enigmatic. Most studies of MS have focused on the role of CD4+ Th1 T cells and many therapeutic strategies have been directed toward ameliorating the activity of this subset. Some of these strategies were effective in experimental autoimmune encephalomyelitis (EAE), a widely used animal model for MS dependent on CD4+ T cells, but paradoxically have worsened disease in MS patients. A great deal of evidence suggests that CD8+ T cells contribute to the pathogenesis of MS and should be considered in designing therapies. CD8+ T cells outnumber CD4+ T cells in MS lesions, and both clonal expansion and enrichment of memory cells is preferentially seen in the CD8+ T cell subset in the brain and cerebrospinal fluid of MS patients. New animal models have been developed that employ myelin-specific CD8+ T cells to induce central nervous system autoimmunity. In a CD8+ T cell model targeting myelin basic protein, clinical signs and pathology distinct from CD4+ T cell-mediated disease were observed that exhibited similarities to some aspects of MS. These differences are consistent with distinct effector mechanisms employed by CD8+ and CD4+ T cells in mediating tissue damage and suggest a need to consider the activity of CD8+ T cells in drug design. This review will focus on our current understanding of the role of CD8+ T cells in MS and the new animal models that allow us to investigate further the pathogenicity of this subset.
Keywords: inflammatory disease, central nervous system (cns), demyelination, experimental autoimmune encephalomyelitis (eae), myelin-associated glycoprotein (mag), lymphocyte, viral infections, cytotoxic t lymphocyte (ctl)
Related Journals
Anti-Cancer Agents in Medicinal Chemistry
Current Bioactive Compounds
Current Drug Safety
Current Drug Targets
Current Medicinal Chemistry
Current Pharmaceutical Biotechnology
Central Nervous System Agents in Medicinal Chemistry
Letters in Drug Design & Discovery
Current Drug Discovery Technologies
Recent Advances in Anti-Infective Drug Discovery
Related Books
Computer-Aided Drug Discovery Methods: A Brief Introduction
Medicinal Plants, Phytomedicines and Traditional Herbal Remedies for Drug Discovery and Development against COVID-19
Frontiers in Drug Design and Discovery
Key Heterocyclic Cores for Smart Anticancer Drug–Design Part II
Key Heterocyclic Cores for Smart Anticancer Drug–Design Part I
Frontiers in Cardiovascular Drug Discovery
Frontiers in Drug Design and Discovery
Frontiers in Anti-Cancer Drug Discovery
Frontiers in Drug Design and Discovery
Anti-Obesity Drug Discovery and Development
2